These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 19002132)

  • 1. Identifying acute porphyria in patients with acute polyneuropathy or encephalopathy.
    Elder GH; Sandberg S
    Nat Clin Pract Neurol; 2008 Dec; 4(12):648-9. PubMed ID: 19002132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abnormal thyroid function and hypercholesterolemia in a case of acute intermittent porphyria.
    Shiue JW; Lee FY; Hsiao KJ; Tsai YT; Lee SD; Wu SJ
    Taiwan Yi Xue Hui Za Zhi; 1989 Jul; 88(7):729-31. PubMed ID: 2809566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is screening for urinary porphobilinogen useful among patients with acute polyneuropathy or encephalopathy?
    Pischik E; Kazakov V; Kauppinen R
    J Neurol; 2008 Jul; 255(7):974-9. PubMed ID: 18574620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute porphyria amongst psychiatric patients.
    Golechha GR; Chatterjee SB; Sethi BB; Agarwal SS
    Indian J Psychiatry; 1981 Oct; 23(4):365-9. PubMed ID: 22058565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Porphyria: genetic and acquired.
    Cripps DJ
    IARC Sci Publ; 1986; (77):549-66. PubMed ID: 3298037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute intermittent porphyria exacerbation following in vitro fertilization treatment.
    New GH; Hsu PY; Wu MH
    Taiwan J Obstet Gynecol; 2016 Apr; 55(2):281-4. PubMed ID: 27125415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of acute porphyria: evaluation of a commercial screening test for urinary porphobilinogen.
    Deacon AC; Peters TJ
    Ann Clin Biochem; 1998 Nov; 35 ( Pt 6)():726-32. PubMed ID: 9838985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Best practice guidelines on first-line laboratory testing for porphyria.
    Woolf J; Marsden JT; Degg T; Whatley S; Reed P; Brazil N; Stewart MF; Badminton M
    Ann Clin Biochem; 2017 Mar; 54(2):188-198. PubMed ID: 27555665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ACUTE HEPATIC PORPHYRIA AND PSYCHOSES: (Experience of twelve years).
    Golechha GR
    Indian J Psychiatry; 1989 Oct; 31(4):319-28. PubMed ID: 21927409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Posterior reversible encephalopathy syndrome in acute intermittent porphyria.
    Zhao B; Wei Q; Wang Y; Chen Y; Shang H
    Pediatr Neurol; 2014 Sep; 51(3):457-60. PubMed ID: 25035140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute intermittent porphyria: clinical analysis of nine cases.
    Chen CC; Thajeb P; Lie SK
    Zhonghua Yi Xue Za Zhi (Taipei); 1994 Dec; 54(6):395-9. PubMed ID: 7850680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemodialysis: a therapeutic option for severe attacks of acute intermittent porphyria in developing countries.
    Prabahar MR; Manorajan R; Sathiyakumar D; Soundararajan P; Jayakumar M
    Hemodial Int; 2008 Jan; 12(1):34-8. PubMed ID: 18271838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Acute intermittent porphyria].
    Tollåli G; Nielsen EW; Brekke OL
    Tidsskr Nor Laegeforen; 2002 Apr; 122(11):1102-5. PubMed ID: 12043053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Yeast, creatinine and false diagnosis of porphyria.
    Schoenfeld N; Sztern M; Mamet R
    Cell Mol Biol (Noisy-le-grand); 1997 Feb; 43(1):81-8. PubMed ID: 9074792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alcohol and Indian porphyrics.
    Saksena HC; Panwar RB; Rajvanshi P; Sabir M; Suri M
    Postgrad Med J; 1991 Sep; 67(791):823-4. PubMed ID: 1946127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute intermittent porphyria: case report and review of the literature.
    Lopes Dv; Valle MA; Taguti J; Taguti RC; Betônico GN; Medeiros FC
    Rev Bras Ter Intensiva; 2008 Dec; 20(4):429-34. PubMed ID: 25307250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening tests for porphobilinogen are insensitive. The problem and its solution.
    Schreiber WE; Jamani A; Pudek MR
    Am J Clin Pathol; 1989 Nov; 92(5):644-9. PubMed ID: 2816816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary excretion of porphyrins, porphobilinogen and δ-aminolaevulinic acid following an attack of acute intermittent porphyria.
    Marsden JT; Rees DC
    J Clin Pathol; 2014 Jan; 67(1):60-5. PubMed ID: 23908454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Late diagnosis of a severe attack of acute intermittent porphyria (AIP)--diagnostic dilemmas].
    Koziołek M; Robaczyk M; Krzyzanowska-Swiniarska B
    Pol Arch Med Wewn; 2004 Sep; 112(3):1101-6. PubMed ID: 15727092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Best practice guidelines on clinical management of acute attacks of porphyria and their complications.
    Stein P; Badminton M; Barth J; Rees D; Stewart MF;
    Ann Clin Biochem; 2013 May; 50(Pt 3):217-23. PubMed ID: 23605132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.